SCHEMBL19082202

SCHEMBL19082202

c1ccc(-c2ccc3cc(-c4c5ccccc5c(-c5ccc6c(c5)sc5c6ccc6c5sc5ccc7ccccc7c56)c5ccccc45)ccc3c2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F9 P00740 3/20 0.39
LIMK1 P53667 2/20 0.39
CYP1A1 P04798 2/20 0.36
CYP1B1 Q16678 2/20 0.36
MCL1 Q07820 1/20 0.35
ESR1 P03372 4/20 0.35
ESR2 Q92731 4/20 0.35
NQO2 P16083 2/20 0.34
NQO1 P15559 1/20 0.34
PIK3CA P42336 1/20 0.33
PI4KA P42356 1/20 0.33
PI4KB Q9UBF8 1/20 0.33
F10 P00742 1/20 0.32
CDK4 P11802 2/20 0.32
CCND1 P24385 2/20 0.32
GPR84 Q9NQS5 1/20 0.32
S1PR4 O95977 1/20 0.32
S1PR5 Q9H228 1/20 0.32
CYP1A2 P05177 2/20 0.32
CYP3A4 P08684 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19082345 0.97 F9 (0.36) F9LIMK1CYP1A1CYP1B1MCL1
SCHEMBL19082294 0.95 ESR1 (0.36) F9LIMK1CYP1A1CYP1B1MCL1
SCHEMBL19082150 0.95 CYP1A1 (0.38) F9LIMK1CYP1A1CYP1B1MCL1
SCHEMBL19082312 0.94 HSD17B1 (0.36) F9LIMK1CYP1A1CYP1B1MCL1
SCHEMBL19082102 0.94 CYP1A1 (0.39) F9LIMK1CYP1A1CYP1B1MCL1
SCHEMBL17944275 0.91 F9 (0.42) F9LIMK1CYP1A1CYP1B1MCL1
SCHEMBL19082342 0.90 F9 (0.35) F9LIMK1CYP1A1CYP1B1MCL1
SCHEMBL19082339 0.90 F9 (0.36) F9LIMK1CYP1A1CYP1B1ESR1
SCHEMBL19082196 0.90 F9 (0.39) F9LIMK1CYP1A1CYP1B1MCL1
SCHEMBL17944346 0.90 CYP1A1 (0.46) F9LIMK1CYP1A1CYP1B1MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 F9 1203/4885LIMK1 440/4885CYP1A1 184/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 F9 1203/4885LIMK1 440/4885CYP1A1 184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.